African American Study of Kidney Disease and Hypertension
Broadcast Dates: Monday, January 18 - Sunday, January 24
Right Click to Download MP3 File (935 KB) | Get Real Player |
Recently I told you about clinical trials and why they’re important to your health. Today, I have a good example to share.
Hi, I’m Dr. Griffin Rodgers, bringing you Healthy Moments from the NIH. I’m the director of the National Institute of Diabetes and Digestive and Kidney Diseases.
Our Institute, known as NIDDK, supported a clinical trial of over 1,000 African Americans with Kidney Disease and high blood pressure. One of the findings was that a drug called an ACE inhibitor actually slows kidney disease that’s caused by high blood pressure.
This finding is important because, for the first time, a specific treatment was identified for reducing the risk of progression to kidney failure. NIDDK communicates this kidney disease research to the public in reader-friendly brochures such as "What African Americans Need to Know."
To read this brochure or get more information, visit our website at NIDDK or MyMajicDC.com . This is Dr. Griffin Rodgers. Join me next week for more Healthy Moments.
Page last updated: August 18, 2011